browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
a9790f02-5714-41fd-ad54-ff5717d930cf
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 19:43:41
Income (reported)
Expenses (reported)
$30,000
Expenses method
A
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

MISSION ROLL CALL

Contact
RAY WHITAKER
Phone
+1 706-414-5483
Address
zip:29710, city:Clover, state:SC, street:PO Box 1373
Client

MISSION ROLL CALL

Nonprofit organization serving veterans

State
SC
Country
US
Effective date
2024-12-02
Issues lobbied + lobbyists (4)

VET — Veterans

HR 740, Veterans' ACCESS Act. Direct outreach, policy discussions, and coordination regarding access to timely care and community care delivery. S 800, Precision Brain Health Research Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). S 862, HBOT Access Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 72, TBI and PTSD Treatment Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 1136, TBI and PTSD Treatment Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 6993, BEACON Act. Direct engagement and coordination with congressional offices and partner organizations related to program structure and implementation pathways. VA funding and appropriations priorities. No specific legislation. Development of briefing materials, survey-informed insights, and engagement with congressional offices regarding VA funding levels, program prioritization, oversight, and cost-effective prevention strategies.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE; Veterans Affairs, Dept of (VA)

BUD — Budget/Appropriations

HR 740, Veterans' ACCESS Act. Direct outreach, policy discussions, and coordination regarding access to timely care and community care delivery. S 800, Precision Brain Health Research Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). S 862, HBOT Access Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 72, TBI and PTSD Treatment Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 1136, TBI and PTSD Treatment Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 6993, BEACON Act. Direct engagement and coordination with congressional offices and partner organizations related to program structure and implementation pathways. VA funding and appropriations priorities. No specific legislation. Development of briefing materials, survey-informed insights, and engagement with congressional offices regarding VA funding levels, program prioritization, oversight, and cost-effective prevention strategies.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE; Veterans Affairs, Dept of (VA)

HCR — Health Issues

HR 740, Veterans' ACCESS Act. Direct outreach, policy discussions, and coordination regarding access to timely care and community care delivery. S 800, Precision Brain Health Research Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). S 862, HBOT Access Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 72, TBI and PTSD Treatment Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 1136, TBI and PTSD Treatment Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 6993, BEACON Act. Direct engagement and coordination with congressional offices and partner organizations related to program structure and implementation pathways. VA funding and appropriations priorities. No specific legislation. Development of briefing materials, survey-informed insights, and engagement with congressional offices regarding VA funding levels, program prioritization, oversight, and cost-effective prevention strategies.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE; Veterans Affairs, Dept of (VA)

MED — Medical/Disease Research/Clinical Labs

HR 740, Veterans' ACCESS Act. Direct outreach, policy discussions, and coordination regarding access to timely care and community care delivery. S 800, Precision Brain Health Research Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). S 862, HBOT Access Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 72, TBI and PTSD Treatment Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 1136, TBI and PTSD Treatment Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 6993, BEACON Act. Direct engagement and coordination with congressional offices and partner organizations related to program structure and implementation pathways. VA funding and appropriations priorities. No specific legislation. Development of briefing materials, survey-informed insights, and engagement with congressional offices regarding VA funding levels, program prioritization, oversight, and cost-effective prevention strategies.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.